BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Life Sciences British Columbia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Life Sciences British Columbia
X-ORIGINAL-URL:https://lifesciencesbc.ca
X-WR-CALDESC:Events for Life Sciences British Columbia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180117
DTEND;VALUE=DATE:20180119
DTSTAMP:20260408T204342
CREATED:20210407T223304Z
LAST-MODIFIED:20211108T222753Z
UID:24319-1516147200-1516319999@lifesciencesbc.ca
SUMMARY:2018 Access to Innovation
DESCRIPTION:On Wednesday\, January 17 and Thursday\, January 18\, 2018\, LifeSciences BC held the 2018 Access to Innovation event. \n2018 ACCESS TO INNOVATION\nThank you to our event supporters! \nBDC Capital joined as co-presenter this year\, following on the success of the first-ever Canadian Corporate Innovation Summit.\nSpeaker Bios: \n2018 Access to Innovation Speakers – Day 1\n2018 Access to Innovation Speakers – Day 2\nDeloitte Conference Materials:\nDeloitte-uk-life-sciences-health-care-predictions-2022 Western Canada Edition \n \nConfirmed Speakers:\n\n\nOhad Arazi: Vice President & General Manager\, TELUS Health Living Labs\nDr. Cedric Bisson: Partner\, Teralys Capital\nEla Borenstein\, Program Director\, BDC Capital\n\n\nVern Brownell: CEO\, D-Wave Systems\nDr. Pieter Cullis\, Director\, NanoMedicines Research Group; Professor\, Department of Biochemistry and Molecular Biology\n\nDr. Elai Davicioni: President & Chief Scientific Officer\, GenomeDX Biosciences\nKarimah Es Sabar: CEO & Partner\, Quark Venture Inc and the Director of the Global Health Sciences Fund\nPamela Fralick: President\, Innovative Medicines Canada\n\nDr. Mark Gelfer: Chairman\, GenXys Health Care Systems Inc.\n\nDr. Tom Hawes: Managing Director\, BlueCross BlueShield Venture Fund\nPeter Jones: Industry Lead – Healthcare\, Microsoft Canada\nDr. Steven Jones\, Associate Director and Head\, Bioinformatics\, Genome Sciences Centre\, Vancouver\nDr. Dermot Kelleher\, Dean\, Faculty of Medicine\, University of British Columbia\nErik Kiss: CEO\, Imaging Reality\nDion Madsen\, Senior Managing Partner\, Healthcare Fund\, BDC Venture Capital\nDr. Steve Mathias: Clinical Assistant Professor\, UBC\nDavid McGovern: Associate Deputy Minister\, Innovation\, Science and Economic Development Canada\nDr. Joby McKenzie: Senior Vice President Business Development\, LifeLabs\nDr. Peter McWilliams: Managing Director\, Sanderling Ventures\nFazil Mihlar: Deputy Minister\, Ministry of Jobs\, Trade & Technology\, Government of British Columbia\nDr. Gail Murphy\, Vice-President Research & Innovation\, UBC\nSue Paish: Healthcare Leader\nDr. Jeff Pike: Clinical Transformation Lead\, Providence Health Care\nDr. Simon Pimstone: President & CEO\, Xenon Pharmaceuticals\, Founder\, SAVE BC\nDr. Mohammed Qadir: President & Chief Scientific Officer\, Fusion Genomics Corporation\nDr. Alan Rabinowitz: Co-Founder\, Chief Medical Officer & a Director PHEMI Health Systems\nDr. Rachael Ritchie: Vice President\, Strategy and Partnerships\, The Centre for Drug Research & Development\nRobert Scully: Director\, Manulife Capital Ventures\nMike Standing\, Leader Life Sciences and Health Care EMEA Region\, Deloitte\nDr. Lesley Stolz: Head\, JLABS California\nBill Tam: Interim Co-Chair\, Canada’s Digital Technology Supercluster\nKaren Wichuk: Executive Lead\, Health City Edmonton\nDr. Peter Zandstra\, Director\, School of Biomedical Engineering\, UBC\, Director\, Michael Smith Laboratories\, UBC\n\nDr. Steven Xanthoudakis: Chief Business Development Officer\, CQDM Quebec Consortium for Drug Discovery\n\n\nConference Partner: \nLuncheon Sponsors: GSK \nPresenting Afternoon Sponsor: \nSession Sponsors:  \nReception Sponsor: \nBreakfast & Morning Refreshment Sponsor:  \nGeneral Supporter: GenomeBC
URL:https://lifesciencesbc.ca/event/2018-access-to-innovation/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/accesstoinnovation2018.jpg
END:VEVENT
END:VCALENDAR